Blue Horseshoe Stocks: Great Start to the Week

T2 Biosystems, Inc. TTOO

This past Thursday morning, we cautioned our readers that TTOO was heavily oversold, and sniffing out a bottom with a massive gap to the upside. As it turned out, our timing on that alert could not have any better. The stock saw its low of .52 that day and hasn’t looked back since. Yesterday, TTOO reached .76 which works out to a three-day upswing of 46%, a modest yet respectable move.

More importantly, the stock is once again taking off on the heels of a fresh PR this morning (below), reaching a new high of 1.13 in premarket trading. That further extends our observed range on this play to 117% as TTOO begins to fill the gap on the chart that we mentioned which runs up to the 1.36 mark.

LEXINGTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) announced today that the United States Centers for Medicare & Medicaid Services (CMS) granted approval for a New Technology Add-on Payment (NTAP) for the T2Bacteria® Panel for FY 2020.

The T2Bacteria Panel, the first and only FDA-cleared test to identify sepsis-causing bacterial pathogens directly from whole blood in 3 to 5 hours without the need to wait for blood culture, is now also the first and only in-vitro diagnostic test to ever receive approval for NTAP. (>>View Full PR)


Options Reviews

SPDR S&P500 (ETF) SPY -  As a fresh options idea to start the week yesterday morning, and in light of the bearish market sentiments that we were sensing in the premarket, we went with SPY Weekly $290-288 Puts as our targets. Early indications ultimately proved to be correct, as the markets tanked on the day, sending those contracts on a huge ride.

The following multi-bag gains were there for taking: 

$290 Puts – Range: 2.27-8.19 – Max Gain: 261%
$289.50 Puts – Range: 1.98-7.30 – Max Gain: 269%
$289 Puts – Range: 1.51-7.10 – Max Gain: 370%
$288.50 Puts – Range: 1.29-5.54  – Max Gain: 329%
$288 Puts – Range: 1.18-6.10 – Max Gain: 417%

____

Allakos, Inc. ALLK - We also signaled interest in the ALLK 08/16 $45-60 Calls yesterday in opposition to the market activity we were observing, and those targets bucked the trend quite nicely, with three out of the four producing notable opportunities on the day:

$45 Calls – Range: 16.41-25.53 – Max Gain: 56%
$55 Calls – Range: 9.00-15 60 – Max Gain: 73%
$60 Calls – Range: 6.75-14.20 – Max Gain: 110%
____

Fresh Idea:
Emerson Electric Co. EMR 08/30 $63-64 Calls
Innovative Industrial Properties, Inc. IIPR 08/16 $100-105 Calls


Extended Watchist: 
ACB, ATRS, TOPS, KALA, PAYS, TELL, MYSZ, PLUG, CARS(Bottom-watch)

Blue Horseshoe Stocks: New Options Ideas & More

Teva Pharmaceutical Industries Ltd. TEVA

We’re very interested in TEVA as a potential bottom bounce play. The stock registered new 52-week lows midway through last week, and has exhibited a solid level of support. Trending up slightly in the premarket, we’re going to be tracking a pair of June options contracts to coincide with what could easily be a significant rebound.

Our specific targets are going to be the TEVA 06/28 $12.50 & $13 Calls, which could present us with sizable opportunities to profit
_____

Sprint Corp. S

We’re also going to set our sights on a range of Sprint options as the company attempts to gain FCC and DOJ approval on its $26B proposed merger with T-Mobile. The review period ends in June, but we’re more interested in the short term capability of the stock to provide us with quick strike chances. We’re going to radar the S Weekly $7-8 Calls.


Adverum Biotechnologies, Inc. ADVM – Review

A stock we recently began tracking, ADVM has been in a fairly continual uptrend since we signaled it for observation on the morning of April 17th. In the last month, the stock has made considerable bullish strides.

From the low we observed on the day of our initial alert, at 5.44, ADVM has gone on to record a high of 9.17. That comes out to an increase of 69%


Extended Watchlist:
TOPS, GERN, GMO, AMRH, TRQ, CREX, FUN, ICON, SQQQ, TMUS, INDY

Blue Horseshoe Stocks: BBBY Options & More

Bed Bath & Beyond, Inc. BBBY

The last time we were mentioning Bed Bath & Beyond, was back in January when the stock was trading just below $14. It’s been in a solid uptrend more recently, reaching over 19.50 yesterday. However, we’re getting a bearish feeling from the chart now, especially following the company’s earnings report for the 4th quarter yesterday postmarket.

The company came fairly close to analyst expectations on earnings, yet recorded same-store sales declines for the seventh quarter in a row as e-commerce players like Amazon continue to horn in on brick-and-mortar reliant chains.

We are going to track a bearish options idea into the end of the week for this chain, with the BBBY Weekly $17.50-17 Puts, with the stock already being down a couple of dollars from yesterday’s highs here in the premarket.
_____

FRESH OPTIONS IDEA:
Fastenal, Inc. FAST 04/18 $62.50-67.50 Calls


Extended Watchlist:
VKTX, EVH, FRED, KNDI, GLG, TOPS

Blue Horseshoe Stocks: MMM Update & More

3M Co. MMM – Update

Fresh for yesterday morning’s report, we decided to highlight some MMM calls on the heels of the company’s earnings report, so we put the MMM Weekly $195-202.50 Calls on the radar.

Thanks to a solid intraday performance wherein the stock ran from a low of 194.20-199.89, there were some huge intraday moves from for traders to take advantage of promptly following the opening bell, which were as follows:

$195 Calls – Range: 2.24-6.00 – Max Gain: 168%
$197.50 Calls – Range: .67-4.34 – Max Gain: 548%
$200 Calls – Range: .71-2.80 – Max Gain: 294%
$202.50 Calls – Range: .27-1.55 – Max Gain: 474%

_____

Fresh Options Ideas:
AAPL Weekly $160-162.50 Calls
SPY Weekly $264-265.50 Calls



TrovaGene, Inc. TROV – Review

We last mentioned TROV on December 18th, and at the time the stock was trading down to an annual low of .503. Since then, we’ve seen a slow and steady recovery, which was kicked into a higher gear yesterday following news of Trovagene and PoC Capital entering an agreement to fund the development of Onvansertib in Metastatic Colorectal Cancer.

The stock ended up hitting .73, marking a 45% rise since we mentioned it. We will want to continue monitoring TROV for further advances from this point forward.


Extended Watchlist:
STAF, CREG, CRMD, EKSO, RGS, CLF, TOPS, WFT, ZYNE, IBN

Blue Horseshoe Stocks: Options Review & More

Options Review

After a tumultuous month on the whole, October came to a solid end with a very strong performance from the markets, and in effect, a good showing by many of the ideas we presented in yesterday’s report.

Take-Two Interactive Software, Inc. TTWO – First we’ll give an update on the calls we made on Tuesday morning for TTWO- the Weekly $122-125 Calls. They started moving immediately, as we mentioned in yesterday’s report, and after another session the gains have piled up even higher.

$122 – 4.00-8.45 (+111%)
$123 – 2.49-7.80 (+213%)
$124 – 2.50-6.80 (+172%)
$125 – 2.50-5.40 (+116%)
_____

 Three of the four fresh options ideas we submitted in yesterday’s report also saw sizable gains on the day.

FB Weekly $150-155 Calls
$150
– 2.46-4.37 (+77%)
$152.50 – 1.46-2.67 (+83%)
$155 – .75-1.40 (+86%)
______

GM Weekly $35-37 Calls
$35 – .92-2.04 (+122%)
$35.50 - .62-1.60 (+158%)
$36 – .34-1.15 (+238%)
$36.50 – .19-.72 (+279%)
$37 – .11-.45 (+309%)
______

SPY Weekly $269.50-271.50 Calls
$269.50 - 2.92-4.42 (+51%)
$270 – 2.57-4.15 (+61%)
$270.50 – 1.98-3.40 (+71%)


Extended Watchlist: 
NFX, IGCC, TREE, TOPS, DCIX, NAVB, CRON